Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012-Reference-Cited by-同舟云学术

Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012

Published:2016-07-29 Issue:37 Volume:7 Page:59820-59833
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Shuncong¹,Sun Huanhuan¹,Xie Zhinan²,Li Jie³,Hong Guobin⁴,Li Dan⁵⁶⁷,Mallampati Saradhi⁸,Zhou Xiuling¹,Zhou Cuiling¹,Zhang Hongyu¹,Cheng Zhibin¹,Shan Hong⁵⁶⁷,Ma Haiqing¹

Affiliation:

1. Department of Oncology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong 519000, China

2. Department of Equipment Management, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong 519000, China

3. Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, China

4. Department of Radiology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong 519000, China

5. Center for Interventional Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, 519000, China

6. Guangdong Provincial Engineering Research Center for Molecular Imaging, Zhuhai, 519000, China

7. Institute of Interventional Radiology, Sun Yat-sen University, Zhuhai, 519000, China

8. Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance;Radiology: Imaging Cancer;2024-01-01

2. Role of TOP2A and CDC6 in liver cancer;Medicine;2023-10-20

3. Development of a magnetic resonance imaging-derived radiomics model to predict microvascular invasion in patients with hepatocellular carcinoma;Quantitative Imaging in Medicine and Surgery;2023-06

4. MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma;International Journal of General Medicine;2023-05

5. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression;Future Oncology;2023-02